Ocean Biomedical, Inc. (OCEA )

Currency in USD Disclaimer
$0.15 -$0.01 (-7.81%)
Open 02/05/2025
$0.14
$0.16
$0.14
$7.79

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol OCEA
  • Company Ocean Biomedical, Inc.
  • Price $0.15
  • Changes Percentage -7.81
  • Change -0.0125
  • Day Low $0.14
  • Day High $0.16
  • Year High $7.79
  • Year Low $0.14
  • Market Cap $5,135,747
  • Price Avg 50 EMA (D) $0.59
  • Price Avg 200 EMA (D) $1.03
  • Exchange NASDAQ
  • Volume 2,248,702
  • Average Volume 3,967,010
  • Open $0.15
  • Previous Close $0.16
  • EPS -0.95
  • PE -0.16
  • Earnings Announcement 2025-02-26 12:00:00
  • Shares Outstanding $34,818,626

Company brief: OCEAN BIOMEDICAL, INC. (OCEA )

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.

OCEA Corporation News

Income Statement